SARA STONE: Open Payments
NPI 1063669521 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 11 payments from 8 companies in 2025. Trend: 2023 $183 · 2024 $448 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| GENZYME CORPORATION | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Organon LLC | 2 | $25 |
| Amgen Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| PENTAX of America, Inc. | 1 | $17 |
| Smith+Nephew, Inc. | 1 | $15 |
Products named: DUPIXENT, Otezla, NUZYRA, INSPIRA, COSENTYX, Bone Anchors with Arthroscopic Delivery System, JADA SYSTEM.
Industry payments across LA — which companies pay providers there.
